OPERA-02: a phase 3 randomized, double-blind, active-controlled study of palazestrant with ribociclib versus letrozole with ribociclib for the first-line treatment of ER+, HER2- advanced breast cancer ...
First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, (GLOBE ...
Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted ...
Three abstracts to be presented at the 101st Annual Meeting of the Western Section of the American Urological Association, including baseline characteristics and demographics for patients enrolled in ...
Biontech Se Sponsored Adr (($BNTX)) announced an update on their ongoing clinical study. BioNTech SE, in collaboration with Genentech, Inc., is ...
TipRanks on MSN
Natera announces data from PROCEED-CRC trial
Natera (NTRA) announced another readout for its ECD program, which is evaluating a blood-based screening test for the detection of CRC and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback